Ancora Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $126K | Hold |
1,000
| – | – | ﹤0.01% | 812 |
|
|
2025
Q1 | $111K | Hold |
1,000
| – | – | ﹤0.01% | 821 |
|
|
2024
Q4 | $137K | Hold |
1,000
| – | – | ﹤0.01% | 786 |
|
|
2024
Q3 | $115K | Hold |
1,000
| – | – | ﹤0.01% | 782 |
|
|
2024
Q2 | $138K | Buy |
+1,000
| New | +$138K | ﹤0.01% | 735 |
|
|
2022
Q3 | – | Sell |
-21
| Closed | -$2K | – | 2079 |
|
|
2022
Q2 | $2K | Buy |
+21
| New | +$2K | ﹤0.01% | 1902 |
|
|
2021
Q3 | – | Sell |
-43
| Closed | -$4K | – | 2236 |
|
|
2021
Q2 | $4K | Buy |
+43
| New | +$4K | ﹤0.01% | 1712 |
|